Global Vaccine promises $5 million to develop Ebola vaccine

The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017.

If the vaccine is given the , GAVI says it will then create a stockpile to help stamp out future outbreaks of the . The vaccine's producer, Merck & Co. Inc., says it will ensure that 300,000 doses are available from May for use in advanced trials and emergency use.

In a statement on Wednesday, GAVI CEO Dr. Seth Berkley said "the world is still worryingly underprepared for potential future health threats."

In 2014—during the biggest-ever outbreak of Ebola—GAVI pledged to spend $300 million to buy Ebola vaccines for poor countries.

Explore further

Donors pledge $7.5 bn to extend child vaccine drive

© 2016 The Associated Press. All rights reserved.

Citation: Global Vaccine promises $5 million to develop Ebola vaccine (2016, January 20) retrieved 17 February 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments